Last Price$86.0(2.7%)
Market Cap$34.9B
LTM Income Tax
$132.8M
YoY Growth
-21.4%
3Y CAGR
+90.5%
5Y CAGR
+75.4%
Stock quality & Intrinsic value
7/10
49.8% overvalued
DexCom, Inc. Income Tax
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Tax | ($30.9B) | $253.0 | $0.0 | $2,357.0K | $0.0 | $9,880.0K | ($97.0K) | ($1,300.0K) | $0.0 | $100.0K | $100.0K | $700.0K | $1,600.0K | $600.0K | $3,100.0K | ($268.6M) | $19.2M | $49.6M | $168.9M | $132.8M |
Overvalued or undervalued?
Check the intrinsic value for DXCM
and see if it's the right time to invest.
DexCom, Inc. (DXCM) Income Tax comparison analysis
General
LTM Income Tax
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
DexCom, Inc.DXCM
$132.8M
(21.4%)
90.5%
75.4%
Median Peer Set
$179.5M
0.0%
9.6%
0.4%
Koninklijke Philips N.V.PHG
$1,042.9M
N/A
N/A
23.4%
Medtronic plcMDT
$933.0M
(28.2%)
19.6%
N/A
Stryker CorporationSYK
$499.0M
(1.8%)
20.2%
0.8%
Boston Scientific CorporationBSX
$436.0M
10.9%
127.6%
N/A
Align Technology, Inc.ALGN
$187.6M
(4.4%)
(7.9%)
10.8%
STERIS plcSTE
$171.5M
49.8%
19.2%
13.6%
Edwards Lifesciences CorporationEW
$171.3M
(17.5%)
(5.7%)
17.8%
Zimmer Biomet Holdings, Inc.ZBH
$82.5M
95.5%
25.3%
N/A
Insulet CorporationPODD
($139.3M)
1,578.3%
N/A
N/A
Abbott LaboratoriesABT
($6,389.0M)
N/A
N/A
N/A
DXCM key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 0.0 0.0% | 2.2 0.0% | 4.6 113.2% | 9.8 112.6% | 29.7 201.8% | 48.6 63.8% | 76.3 56.8% | 99.9 31.0% | 160.0 60.2% | 259.2 62.0% | 402.0 55.1% | 573.3 42.6% | 718.5 25.3% | 1,031.6 43.6% | 1,476.0 43.1% | 1,926.7 30.5% | 2,448.5 27.1% | 2,909.8 18.8% | 3,622.3 24.5% | 4,033.0 11.3% |
| Cost of Goods Sold (COGS) | 0.0 | 11.0 | 12.7 | 15.4 | 26.0 | 30.2 | 40.4 | 53.3 | 59.9 | 82.9 | 123.6 | 194.9 | 226.4 | 367.7 | 544.5 | 646.6 | 768.0 | 1,026.7 | 1,333.4 | 1,567.3 |
% margin | 0.0 0.0% | (8.8) (405.1%) | (8.1) (175.3%) | (5.5) (56.2%) | 3.7 12.3% | 18.4 37.9% | 35.8 47.0% | 46.6 46.6% | 100.1 62.6% | 176.3 68.0% | 278.4 69.3% | 378.4 66.0% | 492.1 68.5% | 663.9 64.4% | 931.5 63.1% | 1,280.1 66.4% | 1,680.5 68.6% | 1,883.1 64.7% | 2,288.9 63.2% | 2,465.7 61.1% |
| Operating Expenses | 32.4 | 40.5 | 38.6 | 47.3 | 49.5 | 63.7 | 80.7 | 102.3 | 129.0 | 197.8 | 335.5 | 442.3 | 534.6 | 850.2 | 789.2 | 980.6 | 1,414.7 | 1,491.9 | 1,691.2 | 1,865.7 |
| Research & Development Expenses (R&D) | 26.8 | 19.4 | 16.1 | 19.6 | 14.3 | 23.2 | 30.7 | 39.5 | 44.8 | 69.4 | 137.5 | 156.1 | 185.4 | 417.4 | 273.5 | 359.9 | 604.2 | 484.2 | 505.8 | 552.4 |
| Selling, General & Administrative Expenses (SG&A) | 5.7 | 21.1 | 22.4 | 27.7 | 35.2 | 40.5 | 49.9 | 62.8 | 84.2 | 128.4 | 198.0 | 286.2 | 349.2 | 432.8 | 515.7 | 620.7 | 810.5 | 1,000.2 | 1,185.4 | 1,285.8 |
% margin | (32.4) 0.0% | (49.3) (2,273.0%) | (46.7) (1,008.8%) | (52.8) (537.0%) | (45.8) (154.4%) | (45.3) (93.1%) | (44.8) (58.8%) | (55.7) (55.8%) | (28.9) (18.1%) | (21.5) (8.3%) | (57.1) (14.2%) | (63.9) (11.1%) | (42.5) (5.9%) | (186.3) (18.1%) | 142.3 9.6% | 299.5 15.5% | 175.4 7.2% | 391.2 13.4% | 597.7 16.5% | 600.0 14.9% |
| Interest Income | 0.0 | 0.0 | 0.0 | 1.2 | 0.4 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.4 | 3.3 | 2.4 | 26.4 | 16.1 | 1.7 | 18.0 | 135.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 7.3 | 8.0 | 1.5 | 0.0 | 0.2 | 0.9 | 0.8 | 0.4 | 0.7 | 12.8 | 22.7 | 60.3 | 84.7 | 102.0 | 18.6 | 20.3 | 0.0 |
| Pre-tax Income | (30,889.7) | (46.6) | (45.9) | (55.2) | (53.5) | (55.2) | (44.7) | (55.8) | (29.8) | (22.3) | (57.5) | (64.9) | (48.6) | (126.5) | 104.2 | 225.0 | 173.9 | 390.8 | 710.4 | 709.0 |
% effective tax rate | (30,858.9) 99.9% | 0.0 (0.0%) | 0.0 0.0% | 2.4 (4.3%) | 0.0 0.0% | 9.9 (17.9%) | (0.1) 0.2% | (1.3) 2.3% | 0.0 0.0% | 0.1 (0.4%) | 0.1 (0.2%) | 0.7 (1.1%) | 1.6 (3.3%) | 0.6 (0.5%) | 3.1 3.0% | (268.6) (119.4%) | 19.2 11.0% | 49.6 12.7% | 168.9 23.8% | 132.8 18.7% |
% margin | (30.8) 0.0% | (46.6) (2,147.6%) | (45.9) (991.5%) | (55.2) (560.9%) | (53.5) (180.3%) | (55.2) (113.4%) | (44.7) (58.7%) | (54.5) (54.6%) | (29.8) (18.6%) | (22.4) (8.6%) | (57.6) (14.3%) | (65.6) (11.4%) | (50.2) (7.0%) | (127.1) (12.3%) | 101.1 6.8% | 493.6 25.6% | 154.7 6.3% | 341.2 11.7% | 541.5 14.9% | 576.2 14.3% |
| EPS | (0.41) | (0.43) | (0.41) | (0.47) | (0.30) | (0.24) | (0.17) | (0.20) | (0.10) | (0.07) | (0.18) | (0.20) | (0.15) | (0.36) | 0.28 | 1.31 | 0.40 | 0.88 | 1.44 | 1.42 |
| Diluted EPS | (0.41) | (0.43) | (0.41) | (0.47) | (0.30) | (0.24) | (0.17) | (0.20) | (0.10) | (0.07) | (0.18) | (0.20) | (0.15) | (0.36) | 0.27 | 1.27 | 0.36 | 0.80 | 1.30 | 1.40 |
% margin | (29.7) 0.0% | (46.6) (2,148.7%) | (43.3) (936.8%) | (49.8) (506.1%) | (43.1) (145.2%) | (51.2) (105.3%) | (41.0) (53.7%) | (49.0) (49.0%) | (21.9) (13.7%) | (13.1) (5.1%) | (46.3) (11.5%) | (49.2) (8.6%) | (19.7) (2.7%) | (74.7) (7.2%) | 213.2 14.4% | 376.8 19.6% | 377.5 15.4% | 565.3 19.4% | 916.7 25.3% | 840.7 20.8% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is DexCom, Inc.'s Income Tax?
As of today, DexCom, Inc.'s last 12-month Income Tax is $132.8M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is DexCom, Inc.'s Income Tax growth rate?
Over the last year, DexCom, Inc.'s Income Tax growth was (21.4%). The average annual Income Tax growth rates for DexCom, Inc. have been N/A over the past three years, 75.4% over the past five years.
3) Is DexCom, Inc.'s Income Tax growth rate Good?
Over the last year, DexCom, Inc.'s Income Tax growth was (21.4%), which is lower than industry growth of 2.3%. It indicates that DexCom, Inc.'s Income Tax growth is Good.